ПРИМЕНЕНИЕ ИНГИБИТОРОВ АНГИОТЕНЗИНПРЕВРАЩАЮЩЕГО ФЕРМЕНТА И БЛОКАТОРОВ КАЛЬЦИЕВЫХ КАНАЛОВ У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЁГКИХ, ПРОТЕКАЮЩЕЙ СО СТАБИЛЬНОЙ СТЕНОКАРДИЕЙ И АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ
Аннотация
В обзоре рассматриваются подходы к выбору антигипертензивного препарата из группы ингибиторов ангиотензинпревращающего фермента и блокаторов кальциевых каналов у пациентов с хронической обструктивной болезнью лёгких, протекающей в сочетании со стабильной стенокардией и артериальной гипертензией.
Литература
Korreja LL, Lebedev TJu, Efremova OA, Proshhaev KI, Litovchenko ES. Problema polimorbidnosti pri sochetanii hronicheskoj obstruktivnoj bolezni legkih i nekotoryh serdechno-sosudistyh zabolevanij. Nauchnye vedomosti. 2013;4(147):12-17. (Russian).
Laratta CR, van Eeden S. Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Cardiovascular Links. BioMed Research International. 2014;11:1-18. http://doi.org/10.1155/2014/528789.
Bova AA, Lapickij DV. Hronicheskaja obstruktivnaja bolezn legkih v sochetanii s ishemicheskoj boleznju serdca. Sovremennye podhody k diagnostike i lecheniju. Minsk: Asobny; 2007. 56 p. (Russian).
Ostroumova OD, Kochetukov AI. Hronicheskaja obstruktivnaja bolezn legkih i komorbidnye serdechno-sosudistyezabolevanija: vzgljad s pozicij rekomendacij [Chronic obstructive pulmonary disease and comorbid cardiovascular disease: in the context of guidelines]. Consilium Medicum. 2018;20(1):54-61. http://doi.org/10.26442/2075-1753_2018.1.54-61. (Russian).
Barsukov AV, Talanceva MS, Korovin AE, Kazancev VA. Problema sochetannogo techenija jessencialnoj gipertenzii i hronicheskoj obstruktivnoj patologii legkih [The problem of essential hypertension and chronic bronchoobstructive pathology comorbidity]. Cardiosomatika. 2012;4(3):12-17. (Russian).
Onishi K. Total management of Chronic Obstructive Pulmonary Disease (COPD) as an independent risk factor for cardiovascular disease. J Cardiol. 2017;2(70):128-134. http://doi.org/10.1016/j.jjcc.2017.03.001.
Rabe KF, Hurst JR, Suissa S. Cardiovascular disease and COPD: dangerous liaisons? European Respiratory Review. 2018;27(149):1-32. http://doi.org/10.1183/16000617.0057-2018.
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013;31(7):1281-1357.
Diagnostika i lechenie pacientov s hronicheskoj obstruktivnoj boleznju legkih i arterialnoj gipertenziej: nacionalnye klinicheskie rekomendacii. RNMOT; 2017. 76 р. (Russian).
Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni A, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. Zakljuchenie jekspertov Evropejskogo obshhestva kardiologov po primeneniju ingibitorov angiotenzinprevrashhajushhego fermenta pri serdechno-sosudistyh zabolevanijah [Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. Racionalnaja farmakoterapija v kardiologii. 2005;1:49-69. http://doi.org/10.20996/1819-6446-2005-1-1-49-69. (Russian).
Polikutina OM, Slepynina JuS, Kacjuba MV, Karetnikova VN. Diffuzionnaja sposobnost legkih kak prognosticheskij marker u pacientov s serdechnoj nedostatochnostju [Pulmonary diffusion capacity as prognostic marker in chronic heart failure]. Cibirskij medicinskij zhurnal [Siberian Medical Journal]. 2012;27(2):29-34. (Russian).
Dmitrenko VV. Arterialnaja gipertenzija i hronicheskaja obstruktivnaja bolezn legkih: sovremennye trebovanija k lecheniju. Vestnik gigieny i jepidemiologii. 2018;4(22):97-98. (Russian).
Deanfield JE, Detry JM, Lichtlen PR, Magnani B, Sellier P, Thaulow E. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind circadian anti-ischemia program in Europe (CAPE Trial). J. Am. Coll. Cardiol. 1994;24(6):1460-1467. http://doi.org/10.1016/0735-1097(94)90140-6.
Dzhaiani NA. Vybor lizinoprila dlja terapii arterialnoj gipertonii u pacientov s soputstvujushhej patologiej [Choice of lisinopril for treatment of hypertension in patients with concomitant diseases]. Racionalnaja farmakoterapija v kardiologii [Rational Pharmacotherapy in Cardiology]. 2014;5(10):565-571. (Russian).
Vorobeva EN, Vorobev RI, Sharlaeva EA, Fomicheva ML, Sokolova GG, Kazyzaeva AS, Batanina IA. Disfunkcija jendotelija pri serdechno-sosudistyh zabolevanijah: faktory riska, metody diagnostiki i korrekcii. Acta Biologica Sibirica. 2016;2(1):21-30. (Russian).
Trisvetova EL, Gubkin SV. Medikamentoznoe lechenie legochnoj gipertenzii (po materialam 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension). Racionalnaja farmakoterapija v kardiologii [Rational Pharmacotherapy in Cardiology]. 2016;1(12):79-86. (Russian).
Mickevich FM, Atroshhenko IE. Osobennosti legochnoj gipertenzii u bolnyh HOBL i principy ee medikamentoznoj korrekcii. Minsk: Zimaletto; 2010. 28 р. (Russian).
Kozhanova IN. Lizinopril v praktike internista v sootvetstvii s sovremennymi rekomendacijami. Medicinskie novosti. 2018;6:35-42. (Russian).
Maksimov ML. Racionalnaja farmakoterapija ishemicheskoj bolezni serdca: b-adrenoblokatory i antagonisty kalcija v lechenii stabilnoj stenokardii. Russkij medicinskij zhurnal. 2014;2:124-128. (Russian).
Oparin AG. Antagonisty kalcija: mehanizm dejstvija i osobennosti klinicheskogo primenenija [Calcium channel blockers: of action and peculiarities clinical usage]. Vostochnoevropejskij zhurnal vnutrennej i semejnoj mediciny [East European Journal of Internal and Family Medicine]. 2014;1:51-56. (Russian).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in highrisk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997. http://doi.org/10.1001/jama.288.23.2981.
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, Zamorano JL, et al. 2013 ESC guidelines on the management of stable coronary disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal. 2013;38(34):2949-3003. http://doi.org/10.1093/eurheartj/eht296.
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Noordegraaf AV, Beghetti M, Ghofrani A, Sanchez MAG, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh TH, Pierard LA, Trindade PT, Zompatori M, Hoeper M. 2015 ESC/ERS Guidelines for the diagnostics and treatment of pulmonary hypertension. European Heart Journal. 2015;1(37):67-119.
Kuchmin AN, Cherkashin DV. Antagonisty kalcija: ot istorii sozdanija k sovremennoj klinicheskoj praktike [Calcium antagonists: from history of creation to modern clinical practice]. Medicinskij sovet [Medical Council]. 2015;17:48-54. (Russisn).
Lupanov VP. Novye Evropejskie metodicheskie rekomendacii 2013 g. po lecheniju stabilnoj ishemicheskoj bolezni serdca. Russkij medicinskij zhurnal. 2014;22(2):98-104. (Russian).
Leonova MV. Klinicheskaja farmakologija i klinicheskaja jeffektivnost amlodipina. Dannye dokazatelnoj mediciny [Clinical pharmacology and clinical efficacy of amlodipine. Evidence-based data]. Medicinskij sovet [Medical Council]. 2014;12:25-32. (Russian).
Anderson TJ, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism? And calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J. Am. Col. Cardiol. 2000;35:60-66. http://doi.org/10.1016/s0735-1097(99)00537-9.
Bova AA. Sovremennye podhody k antigipertenzivnoj terapii u bolnyh arterialnoj gipertoniej i hronicheskoj obstruktivnoj boleznju legkih. Mezhdunarodnye obzory: klinicheskaja praktika i zdorove. 2014;3:89-97. (Russian).
